Stable antibody-producing murine hybridomas

Science
R T Taggart, I M Samloff

Abstract

A method is described for obtaining antibody-producing hybridomas that are preferentially retained in cultures of fused mouse spleen and myeloma cells. Hybridomas are produced by fusing mouse myeloma cells that are deficient in adenosine phosphoribosyltransferase (APRT) with mouse spleen cells containing Robertsonian 8.12 translocation chromosomes. The cell fusion mixtures are exposed to a culture medium that can be utilized only by APRT-positive cells, which results in the elimination of both unfused APRT-deficient myeloma cells and non-antibody-producing APRT-deficient hybridomas that arise by segregation of the 8.12 translocation chromosomes containing the APRT genes and the active heavy chain immunoglobulin gene.

References

Sep 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·H HengartnerE Müller
Oct 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·U Francke, R T Taggart
Jan 1, 1978·Cytogenetics and Cell Genetics·M T Davisson, T H Roderick
Apr 1, 1976·European Journal of Immunology·G KöhlerC Milstein
Jul 1, 1976·European Journal of Immunology·G Köhler, C Milstein
Nov 29, 1976·Chromosoma·E CapannaM V Civitelli
Aug 25, 1971·Nature: New Biology·M F Lyon
Jun 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·U Francke, R T Taggart
Jun 1, 1980·The Journal of Experimental Medicine·P D'EustachioF H Ruddle
May 28, 1981·The New England Journal of Medicine·B A DiamondM D Scharff
Jan 1, 1981·Hybridoma·G Köhler

❮ Previous
Next ❯

Citations

May 5, 1998·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Q ZhuZ Kaprielian
May 24, 2000·Developmental Dynamics : an Official Publication of the American Association of Anatomists·P D HenionJ A Weston
Dec 18, 2001·European Journal of Immunology·C GouaillardB Rubin
May 1, 1994·Annals of Neurology·L S HigginsB Cordell
Mar 5, 1990·Biotechnology and Bioengineering·K K Frame, W S Hu
Jan 1, 1990·Journal of Clinical Laboratory Analysis·H MoscosoF A Garver
Jan 1, 1990·Archives of Virology·I Greiser-WilkeB Liess
Jul 1, 1992·Annals of Hematology·M ShyamalaF A Garver
Jul 1, 1986·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·N YabeM Takada
Jun 1, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Janneta TcherkassovaRicardo Moro
Jan 15, 1987·Clinica Chimica Acta; International Journal of Clinical Chemistry·S C HuangK Takahashi
Mar 18, 1985·Journal of Immunological Methods·R J Westerwoudt
Aug 3, 1987·Journal of Immunological Methods·S R SamoilovichA J Macario
Aug 1, 1989·Journal of Steroid Biochemistry·J G LewisP A Elder
Jan 1, 1987·Tissue & Cell·M E SchellingH J Granger
Sep 1, 1991·Enzyme and Microbial Technology·K K Frame, W S Hu
Sep 1, 1990·Veterinary Immunology and Immunopathology·A J AinsworthT Greenway
Jan 1, 1983·Biotechnology Advances·D E Bu'lock
Feb 18, 1999·Journal of Immunological Methods·J A LebrónS Ou
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R R Isberg, J M Leong
Jun 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·W M GallatinW G Carter
Feb 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·K Ikuta, I L Weissman
Nov 1, 1987·The Journal of Cell Biology·R DubreuilD P Kiehart
Apr 1, 1992·The Journal of Cell Biology·N NarulaJ L Stow

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.